VERI-Q
LIVE

Serial Number

79279268

Owner

MiCo BioMed Co., Ltd.

Attorney

Sang Ho Lee

Filing Date

Dec 24, 2019

Add to watchlist:

No watchlists yet
View on USPTO

VERI-Q Trademark

Serial Number: 79279268 • Registration: 6358205

VERI-Q is a trademark filed by MiCo BioMed Co., Ltd. on December 24, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

MiCo BioMed Co., Ltd. (2 trademarks)

3F, Ga-dong, 54, Changeop-ro,
Seongnam-si Gyeonggi-do 13449 , KR

Entity Type: 03

Trademark Details

Filing Date

December 24, 2019

Registration Date

May 25, 2021

Published for Opposition

March 9, 2021

Goods & Services

Diagnostic test reagents for medical or veterinary purposes; medical diagnostic test strips; reagent paper for medical purposes; diagnostic test reagents for medical purposes; reagents for use in medical genetic testing; chemical preparations for use in DNA medical analysis; biological preparations for the prevention and treatment of infectious diseases, tropical fever disease, and food pathogen disease; medical diagnostic test strips for blood analysis, urine analysis, saliva analysis, tear production in dry eyes, and for blood glucose levels

Diagnostic apparatus for medical purposes for testing blood sugar levels, cancer cells, DNA, RNA, or for measuring blood sugar, blood and blood components, and glycated hemoglobin; cholesterol measuring apparatus for medical purposes; apparatus for clinical diagnosis for measuring diabetes, measuring glycated hemoglobin, measuring blood, counting blood cell, and for testing DNA and RNA; apparatus for magnet therapy; haemocytometers; devices for measuring blood sugar; filters for blood and blood components; blood testing apparatus; apparatus for blood analysis; apparatus for taking blood samples; diabetes measuring apparatus; glycated hemoglobin measuring apparatus; lancets; apparatus for DNA and RNA testing for medical purposes; immunofluorescence analysis apparatus for medical purposes being immunoassay analyzers for medical diagnostic uses; medical health signal measuring instruments in the nature of instruments for measuring pulse, electrocardiogram, blood components, blood pressure, heart rate, body temperature, body mass, body fat, and blood glucose; chromatographic instruments for medical use, namely, instruments for measuring amino acid, hormone, and protein; medical devices for obtaining body fluid sample for analysis; measuring instruments for medical purposes, namely, instruments for measuring blood pressure, cholesterol, blood glucose, cardiac output, lung capacity, and other physiological and cardiovascular parameters; cartridges for medical purposes, namely, containers for gas, liquid, and gel sold empty for medical use; medical apparatus for diagnostic use in the field of infectious diseases, tropical fever disease, and food pathogen disease, namely, well plates for enzyme linked immunosorbent assay and well plate for polymerase chain reaction

Laboratory apparatus, namely, reagent cartridges used for extracting and analyzing DNA, reagent containers used for DNA analysis apparatus, DNA analysis apparatus, gene analyzing and extracting devices, devices for analyzing polynucleic acid sequence, devices for analyzing gene information, DNA sequencing devices, devices for analyzing protein sequence, reagent cartridges used for protein analysis apparatus, reagent containers used for protein analysis apparatus, diagnostic apparatus for use in the detection of pathogens for laboratory or research use, all of the foregoing not for medical purposes; gene amplifiers; DNA chips; DNA microarray used for scientific or laboratory research; biochips for research or scientific purposes; biochip analyzing apparatus, namely, gene amplifiers, and laboratory gene analyzing and extracting devices; computer programs, recorded for editing images, sound, and video, for use in database management, and for use in electronic storage of data; computer programs, downloadable for use in database management, use in electronic storage of data, use as a spread sheet, and word processing; computer software applications, downloadable for use in database management, and use in electronic storage of data; plate for analyzing genes for research or scientific purposes; multiple well plates for use in the sample preparation and purification of DNA samples for research or scientific purposes; micromulti-well plates which can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research

Diagnostic reagents, other than for medical or veterinary purposes; reagent paper, other than for medical or veterinary purposes; reagents for nucleic acid amplifications for scientific or laboratory purposes; reagents for nucleic acid amplification, other than for medical purposes; chemical reagents for use in genetic research, namely, genetic identity testing

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 25, 2026 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 6, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 6, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 6, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 6, 2022 REAP
NEW REPRESENTATIVE AT IB RECEIVED
Oct 27, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 4, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 10, 2021 FICS
FINAL DISPOSITION PROCESSED
Sep 10, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 25, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
May 25, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 9, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 9, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Mar 7, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 17, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 17, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 17, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 29, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 28, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 28, 2021 CRFA
ASSIGNED TO LIE
Jan 25, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 14, 2020 TROA
REFUSAL PROCESSED BY IB
May 1, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 14, 2020 RFCS
REFUSAL PROCESSED BY MPU
Apr 14, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 27, 2020 RFCR
NON-FINAL ACTION WRITTEN
Mar 26, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 20, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 29, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 25, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 20, 2020 REPR